Clinical Trial Search

Primary: Number of Women in Each Group Who Require a Return Visit to the Clinic for a Serum hCG Measurement, Ultrasound or Clinical Examination at One Week to Confirm Complete…

Primary: Psychological Morbidity — 10; 10; 5; 5 score on a scale

Primary: Feasibility of Application — 4.47; 4.52; 4.16; 4.26 units on a scale

Primary: Contraceptive Use — 93.43; 94.46; 94.10 percentage of surveys — p=1.0

Primary: Intention to Initiate Contraception — 59 Participants

Primary: Percentage of Participants With Verified Prescription Contraceptive Use at the 6-month Assessment — 5; 14; 23 Participants — p=<.001

Primary: Number of Participants Who Experienced Assessed Pregnancy Outcomes — 1; 0; 1; 0 Participants

Primary: Weight — 3.2; 6.8; 7.0 percent weight lost — p=<0.05

Primary: Potential Efficacy: Effective Contraception Initiation Rates [Time Frame: Enrollment, 12 Weeks Post-enrollment (2 Weeks Post Close of Intervention)] — 14; 14 Participants

Primary: Percentage of Participants Recruited to Study Protocol — 37.5 percentage of participants

Primary: Number of Participants With Continuous Use of Highly Effective Contraceptives Over 9 Months. — 39; 29 Participants — p=>.05

Primary: Continuation at 1 Year — 21; 30 participants

Primary: Number of Participants With Ovulation With Implant-alone — 7; 0 Participants

Primary: Placental Retention Rate — 26; 8; 24 participants — p=0.05

Primary: Contraceptive Acceptability and Use of Contraceptives During the 6-month Follow-up — 121; 86 participants

Primary: Family Planning Visit and Long-acting Reversible Contraception Use at Three and Six Month Follow-up by Condition. — 2; 7; 2; 7 Participants

Primary: Adolescent Feasibility of Intervention — 4.5; 4.7 score on a scale

Primary: Number of Women 'Prepared for Pregnancy\ — 3 participants

Primary: Number of Non-pregnant Couples With Modern Contraceptive Use in Past 3 Months — 265; 295 Couple

Primary: Continuation Rates — 82; 78; 83 participants

Primary: ABILITY TO FOLLOW POSTPARTUM TEENS FOR 1 YEAR. — 22; 16 Participants

Primary: Number of Participants With Known Pregnancy Outcomes, by Type of Pregnancy Outcomes in Women Intentionally or Unintentionally Vaccinated With Boostrix During Pregnancy…

Primary: Number of Participants With Uneventful Clinical Resolution of a Pregnancy of Unknown Location Without Change From the Initial Management Strategy — 31; 42; 45 Participants

Primary: Reproductive Life Goal Behavioral Intentions — 3.6; 2.7; 3.3; 3.0 score on scale

Primary: Percentage of Pregnancies Prevented (PPP) — 77.5; 36.9 percentage of pregnancies prevented — p=<0.0001

Primary: Willingness to Participate in Research While Pregnant — 319; 39; 288; 70 Participants

Primary: Self-reported Uptake of Effective Ongoing Contraception (Not Condoms) — 5; 13; 22; 0 participants — p=<0.001

Primary: IUD Expulsion — 11 Participants

Primary: Percentage Change in Current Modern Contraceptive Use — -1.1; 1.4; 1.5 percentage of participants

Primary: Successful Expulsion of Fetus and Placenta Within 48 Hours — 60; 47 participants — p=<0.05